Maher Khaled, who managed intellectual property arising from medical research at University of Queensland, has joined Preveceutical Medical as director of international operations.

Monash University has spun out Cincera Therapeutics, which will work on treatments for metabolic syndrome and type-2 diabetes-related conditions.

University of Sydney has spun out Kinoxis, which will develop a treatment for substance abuse disorders, with $3.9m in series A funding from a consortium led by Uniseed.

Allergan has acquired Elastagen, a spinout from University of Sydney, for an upfront consideration of $95m and contingent, commercial payments.

FluroSat has also received funding from cotton industry-focused public-private partnership CRDC for its remote crop imaging platform.

Jay Hetzel has become chairman at Uniquest, bringing more than 20 years of life science and commercialisation expertise accrued at the Csiro research agency.

The commercialisation firm, which launched operations down under earlier this year, has appointed several members to its senior executive team.